Q1 guidance miss masks margin crunch; H2 recovery unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Missed Q1 ₹400 Cr guidance (delivered ₹295 Cr, -26%). No formal FY27 revision; pivoting to H2 without near-term milestones.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Apollo missed Q1 FY27 revenue guidance by 26% (₹295 Cr vs ₹400 Cr) and reported a net loss of -₹11.1 Cr. Management's claim of normalized 7% EBITDA is unverified; the actual P&L and future recovery depend entirely on post-monsoon volume uptake and sustained price stability—both unproven in the call. Risk is high.
₹295.4 Cr
Revenue · +7.4% YoY₹-11.1 Cr
Reported PAT · −236.2% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Q1 revenue guidance over ₹400 Cr
MISSDelivered ₹295.4 Cr, a 26% miss. No formal revision disclosed.
Normalized EBITDA 7% consolidated despite reported loss
MISSNet loss -₹11.1 Cr; inventory write-down magnitude unquantified. Normalized claim unverified in P&L.
Flat volume YoY = market share gain as smaller players hurt by volatility
UnverifiedNo data on competitor impact, industry volume contraction size, or absolute market share. Claim unsubstantiated.
CPVC grew YoY despite flattish overall volumes
UnverifiedManagement asserts growth; no quantified numbers. Cannot verify.
Inventory losses were majority of EBITDA miss; margins normalizeable to 7-8%
OVERSTATEDExact inventory loss refused ('simple math you can do'). Actual P&L shows loss. Normalization optical.
Earnings quality
What changed since the last call
Revenue guidance missed
DowngradeQ1 FY27 target >₹400 Cr; delivered ₹295.4 Cr (-26%). No formal revision of FY27 target; just pivoting to H2 narrative.
Profitability turned negative
DowngradeQ1 net loss -₹11.1 Cr vs prior profit. Margin compression from inventory write-downs + aggressive pricing not pre-warned. QoQ PAT down 8,584%.
Volume growth zero
DowngradeFY26 flat YoY; Q1 FY27 also flat YoY. No organic volume growth in 4+ quarters despite aggressive 5-year ₹5,000 Cr guidance.
Window profile launched
NewNew D2C business targeting 7-8% of FY27 revenue (unproven at scale). Long-term potential 15%; near-term margin drag from team build-out.
Kisan restructuring ongoing
NeutralMerger scheme filed; plant closures, brand relaunch progressing. Still loss-making; only ~1% cost synergies quantified. Benefits timeline unclear.
The Q&A
Moderate pressure but not sustained. DAM Capital (Aasim) pressed hard on 7-8% margin confidence amid high competitive intensity and volume focus; management held firm but declined to quantify inventory loss amount ('simple math'). No analyst directly challenged the ₹400 Cr Q1 miss. Distributor caution (Roshan, Antique) and Kisan losses (Karan, AM Tech) prompted explanations but were not rebutted with hard data.
MIP & PVC pricing impact — Sneha, Nuvama
AnsweredMIP at ₹82/kg provides floor. Market 1-2% premium above floor. Prices stable in near term; cannot fall below MIP. Demand good due to low channel inventory.
Demand segment slowdown drivers — Sneha, Nuvama
AnsweredApril worst (30% PVC crash); both segments hit. May-June recovery pent-up. July decent. Monsoon to soften 15-20 days; construction will dominate H2.
One-off margin impact quantification — Sneha, Nuvama
PartialNormalized EBITDA 7% (8% Apollo, 6% Kisan). Varanasi + Window = 0.5% cost drag. Rest was inventory write-down. [Refuses to quantify write-down amount.]
Volume & margin guidance reaffirmation — Sneha, Nuvama
AnsweredHigh double-digit volume growth FY27 & coming years. 7-8% EBITDA next 12-15 months; gradual improvement after.
Window profile revenue targets — Ameya, Value Equity
Partial7-8% of FY27 revenue target. 10% at full capacity; 15% long-term. Flat volume vs contracting industry suggests market share gain.
Q2 YoY growth outlook — Sagar, Bajaj Alternate
AnsweredQ2 will be double-digit growth on YoY basis.
Five-year targets reconfirmation — Sagar, Bajaj Alternate
AnsweredFY31: four large plants (₹800-1,000 Cr each) + PVC pipes at 10%+ EBITDA. Allied products ₹1,000 Cr total. 25% ROC math maintained.
CAPEX funding approach — Sagar, Bajaj Alternate
AnsweredAlmost net cash. ₹600-700 Cr FY27-31 CAPEX; 70-80% from internal cash. No debt or equity needed.
New product margin expectations — Sagar, Bajaj Alternate
Answered10-15% EBITDA margin target. Focus on 25% ROC.
Government capex & Nal Se Jal pipeline — Neha, Nuvama
AnsweredBudget support seen but tender & disbursement slow. Nothing yet 4 months in FY27. Hoping for activity in next 3-4 months.
CPVC growth & Lubrizol partnership — Neha, Nuvama
AnsweredCPVC grew YoY despite flattish overall. Tie-up showing results. Co-branding activities underway; major growth contributor.
FY27-28 CAPEX quantum — Neha, Nuvama
Answered₹200 Cr total (₹100 Cr/year). Funded from operating cash; WC release expected Sep onwards.
Working capital release initiatives — Aasim, DAM Capital
AnsweredInventory 80 days; target rationalize to 30 day NWC (from 45). Debtors stable 30 days; target 25 by year-end. Creditor terms to improve with volume. 10-15 day WC release scope by FY28.
Confidence in 7-8% margins amid competition — Aasim, DAM Capital
PartialYes. Q1 showed it (normalized 7%). High push sales period. As normalization occurs, 50-100 bps room. Varanasi & Window stabilization add another 50-100 bps.
Inventory loss magnitude disclosure — Aasim, DAM Capital
DodgedNormalized 7% EBITDA; majority was inventory. [Declines to quantify; says 'simple math'.]
PVC resin supply & MIP effect — Aasim, DAM Capital
AnsweredPort congestion temporary. Global availability normal. MIP provides base; people importing again now. No supply disruption foreseen.
Segment demand evolution (agri, plumbing, infra) — Roshan, Antique
AnsweredConstruction (60% sales) ok in May-June. Agri slow due to monsoon; normal in Mar-Apr but April crashed with PVC prices. Construction now dominant.
Distributor restocking & July demand — Roshan, Antique
AnsweredToo early to restock; prices too volatile historically. Very cautious. If stability sustains 10-15 days, restocking will start and boost Q2.
Varanasi plant ramp trajectory — Karan, AM Tech
AnsweredTotal capacity ₹300 Cr. Target 30% utilization FY27. Then 50%, 60%, 70% in FY28, balance FY29.
Kisan losses vs merger confidence disconnect — Karan, AM Tech
PartialSilver lining: 5-6% EBITDA at business level (hidden by inventory losses in P&L). Volume flat 5.5k tons/qtr but can do 8-8.5k. Team rationalization, brand relaunch progressing. Macro improving.
Segment-wise volume growth — Karan, AM Tech
AnsweredFY26 & Q1 flat. CPVC strong, Window ramping, Bath flat, Water tank double-digit, Govt infra near-zero (major drag), Fittings single-digit.
ROC profile for ₹5,000 Cr revenue target — Karan, AM Tech
AnsweredGross block ₹1,500 Cr; WC ₹300-400 Cr; total capital ₹1,800-1,900 Cr. On ₹5,000 Cr @ 10-12% EBITDA (₹500-600 Cr), ROC = 25%. Math unchanged.
₹200 Cr CAPEX allocation & South India timing — Karan, AM Tech
AnsweredPending Varanasi, brownfield, new products. South India: FY27 land, FY28 Q2+ construction. Milestones: Varanasi & Maharashtra ramp first.
Kisan merger cost synergies — Shaurya, Equirus
PartialAlready achieved: single sourcing, finance/tech. Remaining: ~1% cost synergies post-merger (separate brands/teams). Timeline not specified.
Regional expansion strategy beyond South — Shaurya, Equirus
AnsweredPlants positioned: Secunderabad (North), Kisan (West: MH/GJ/MP), Varanasi (UP/Bihar/Odisha), planned South. 1-2 satellite plants post full-ramp.
Guidance
FY27 high double-digit volume growth
MediumUnquantified percentage. Q1 flat; recovery contingent on post-monsoon demand + price stability. Distributor caution persists as of late July.
Q2 double-digit growth YoY
MediumConditional on 10-15 day price stability window and monsoon exit. May not materialize if volatility or caution persists.
Window profile 7-8% of FY27 revenue
LowBrand-new D2C product. Unproven scale-up. Scales to 10% at capacity; long-term 15%. High execution risk.
FY31 ₹5,000 Cr revenue; 4 plants ₹800-1,000 Cr each; 10%+ EBITDA
MediumQuantified target; mechanism weak. Varanasi 30% FY27, Kisan still in recovery, South plant not yet started. Macro-dependent.
7-8% EBITDA next 12-15 months
LowQ1 actual net loss -₹11.1 Cr. Normalized 7% unverified. Contingent on volume uptake + cost absorption; high execution risk.
Gradual margin improvement post 12-15 months
MediumVaranasi & Window stabilization to add 50-100 bps. Timeline depends on volume ramp; unproven.
New product margins 10-15% EBITDA, 25% ROC target
LowAggressive target. Nascent businesses (Window, Water tank). No evidence of delivery yet.
FY27-28 ₹200 Cr CAPEX (₹100 Cr/year)
HighVaranasi completion, brownfield expansions, new products. Funded from internal cash flow; 70-80% coverage from operations.
FY31 ₹600-700 Cr cumulative CAPEX for ₹5,000 Cr revenue target
MediumSouth India plant FY27 land acquisition, FY28 Q2+ construction. Dependent on Varanasi/Maharashtra ramp-up milestones.
Risks the call surfaced
Guidance miss without revision
HighQ1 revenue missed ₹400 Cr guidance by 26% (₹295.4 Cr delivered). No formal lowering of FY27 target; just pivoting to H2 recovery narrative. Visibility gap erodes credibility.
Profitability collapse
HighNet loss -₹11.1 Cr in Q1. Inventory write-downs claimed as 'majority' but unquantified. Normalized 7% EBITDA unverified. Actual margin trajectory unknown.
Volume stagnation
HighQ1 volume flat YoY; FY26 also flat. No growth in 4+ quarters. Claim of market share gain from smaller player disruption is unsubstantiated; industry contraction size unknown.
PVC price volatility
HighApril 30% PVC crash; May stabilized. MIP floor at ₹82/kg but global cycles may persist. Channel partners remain very cautious; restocking delayed.
Distributor caution & demand uncertainty
HighDistributors 'very, very cautious' on restocking even with PVC stable (as of late July). Require sustained 10-15 day stability before major restock. Q2 upside unconfirmed.
Varanasi plant ramp-up execution risk
HighVaranasi targeting 30% utilization in FY27 (~₹90 Cr). Any shortfall delays ₹5,000 Cr revenue roadmap. Execution unproven; macro-dependent.
Kisan subsidiary losses & merger risk
HighKisan loss-making 3+ quarters; management claims 5-6% EBITDA at business level (optical) but P&L shows losses. Only ~1% cost synergies quantified; integration timeline unclear.
Government capex pipeline stalled
MediumNal Se Jal budget support seen but no tenders/disbursements yet 4 months into FY27. O-PVC/HDPE volumes near-zero; major drag on overall growth.
Window profile nascent & unproven
MediumWindow profile targeting 7-8% of FY27 revenue; scales to 10%, long-term 15%. D2C model new; team build-out inflating costs. Execution risk high.
South India plant timing uncertain
MediumSouth India plant in land ID phase; FY27 land acquisition, FY28 Q2+ construction start. Delays if Varanasi/Maharashtra ramp miss. Geographic footprint expansion uncertain.
Management
Score 6/10. Evasive on specifics; avoids quantifying inventory loss ('simple math'), margin bridge, and segment contribution. Pivots from Q1 miss to H2 narrative without concrete milestones. Claims of normalized 7% EBITDA unverified in actual P&L. Poor track record. Missed Q1 ₹400 Cr revenue guidance by 26% (₹295.4 Cr delivered). Volume flat FY26 & Q1; zero growth in 4+ quarters. Kisan subsidiary bleeding despite merger confidence.
1 · Aug-Sep 2026
PVC price stability window; if ₹82/kg holds 10-15 days, distributor restocking expected to accelerate
2 · Sep-Oct 2026
Monsoon exit; construction & agri demand rebound. Pent-up demand from Q1 soft quarter may drive H2 volume.
3 · Q2 FY27 onwards
Varanasi plant ramp-up; 30% utilization target. Shortfall signals execution risk and delays ₹5,000 Cr roadmap.
Risk is high.
Informational and educational content only. Not investment advice.